🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an open, exploratory clinical study to evaluate the safety an...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2022-06-01
Trial ID
NCT05410717
Treatments Being Tested
This study tests the safety and preliminary anti-tumor activity of an inves...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-02
Trial ID
NCT07486089
Treatments Being Tested
Background: Cancers that spread into the thin tissue lining your lungs (pl...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2024-01-31
Trial ID
NCT05375825
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07523529
This study tests the safety and preliminary anti-tumor activity of an inves...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-02
Trial ID
NCT07510802
Treatments Being Tested
Background: Over 230,000 new lung cancer cases are diagnosed every year in...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-09-11
Trial ID
NCT04027946
Treatments Being Tested
Phase 1 - Safety and Proof of Concept...
Status
Terminated
Location
University of Pennsylvania
Start Date
2023-02-06
Trial ID
NCT05623488
Treatments Being Tested
This Phase 1/2, open-label, biomarker-guided platform study evaluates the s...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07510828
Treatments Being Tested
The goal of this study is to test autologous logic-gated Tmod™ CAR T-cell p...
Status
Recruiting
Location
Banner Health
Start Date
2024-04-03
Trial ID
NCT06051695
Treatments Being Tested
This is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose ...
Status
Recruiting
Location
Context Investigational Site
Start Date
2025-03-31
Trial ID
NCT06756035
Treatments Being Tested